Medicinal products used for the treatment and prophylaxis of COVID-19
Currently, the most relevant public and personal health problem is the new coronavirus-induced COVID-19 disease. In view of the pandemic emergency situation, the rapid spread of the infection, the severe condition of some patients, and the high mortality rate, there is an urgent need to treat patie...
Saved in:
Main Author: | A. Vaitkevičius |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2020-06-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/27751 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 – a new challenge for the medical community
by: D. Valančius, et al.
Published: (2020-06-01) -
Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort study
by: Altynay Shigayeva, et al.
Published: (2025-02-01) -
COVID-19 infection: neurological symptoms and encephalitis
by: A. Jasionis, et al.
Published: (2020-06-01) -
COVID-19 Vaccine Hesitancy Among Various Segments of the Population in Turkey: A Literature Review
by: Sezer Okay
Published: (2025-01-01) -
Reflections on COVID-19: A Literature Review of SARS-CoV-2 Testing
by: Chin Shern Lau, et al.
Published: (2024-12-01)